SEXHF yields 5.15% · PFE yields 6.13%● Live data
📍 SEXHF pulled ahead of the other in Year 1
Combined, SEXHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEXHF + PFE for your $10,000?
Sichuan Expressway Company Limited, together with its subsidiaries, invests in, constructs, operates, and manages expressway infrastructure projects in Sichuan Province, the People's Republic of China. It operates through five segments: Toll Roads and Bridges; City Operation; Financial Investment; Energy Investment; and Transportation, Tourism, Culture, and Education. The Toll Roads and Bridges segment engages in the operation of expressways and a high-grade toll bridges. The City Operation segment provides construction and upgrade services under the service concession arrangements and construction contracts, and advertising services, as well as engages in the investment, development, and rental of properties along expressways. The Financial Investment segment is involved in finance lease operation, financial investment, and factoring businesses. The Energy Investment segment operates gas stations along expressways; and sells petrochemicals and other oil products. The Transportation, Tourism, Culture, and Education segment engages in the education operations. It also offers logistics and property development services. Sichuan Expressway Company Limited was incorporated in 1997 and is based in Chengdu, the People's Republic of China.
Full SEXHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.